None
Quote | Alector Inc. (NYSE:ALEC)
Last: | $ |
---|---|
Change Percent: | 0.87% |
Open: | $30.00 |
Close: | $30.26 |
High: | $31.10 |
Low: | $29.47 |
Volume: | 421,893 |
Last Trade Date Time: | 02/12/2020 04:40:05 pm |
News | Alector Inc. (NYSE:ALEC)
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...
SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB...
Message Board Posts | Alector Inc. (NYSE:ALEC)
Subject | By | Source | When |
---|---|---|---|
Where's the love on gettin' in early, ughhh, | Porterhouse10 | investorshub | 07/06/2021 5:39:35 PM |
Shazamm | Planopenny | investorshub | 07/06/2021 4:43:46 PM |
Boom!! | Planopenny | investorshub | 07/02/2021 8:36:10 PM |
Out with a 36% gain | tw0122 | investorshub | 07/02/2021 2:02:38 PM |
Parkinson's in collaboration with $GSK | tw0122 | investorshub | 07/02/2021 12:07:02 PM |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...
SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB...
SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Co...